European Journal of Cancer
Volume 45, Issue 6 , Pages 1067-1079 , April 2009

The cure of cancer: A European perspective

  • Silvia Francisci

      Affiliations

    • Cancer Epidemiology Unit, National Center for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
    • Corresponding Author InformationCorresponding author: Tel.: +39 0649904291; fax: +39 0649904285.
  • ,
  • Riccardo Capocaccia

      Affiliations

    • Cancer Epidemiology Unit, National Center for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
  • ,
  • Enrico Grande

      Affiliations

    • Cancer Epidemiology Unit, National Center for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
  • ,
  • Mariano Santaquilani

      Affiliations

    • Cancer Epidemiology Unit, National Center for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
  • ,
  • Arianna Simonetti

      Affiliations

    • Cancer Epidemiology Unit, National Center for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
  • ,
  • Claudia Allemani

      Affiliations

    • Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
  • ,
  • Gemma Gatta

      Affiliations

    • Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
  • ,
  • Milena Sant

      Affiliations

    • Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
  • ,
  • Giulia Zigon

      Affiliations

    • Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
  • ,
  • Freddie Bray

      Affiliations

    • The Cancer Registry of Norway, N-0310 Oslo, Norway and Dept. of Biostatistics, Institute for Basic Medical Sciences, University of Oslo, Norway
  • ,
  • Maryska Janssen-Heijnen

      Affiliations

    • Department of Research, Eindhoven Cancer Registry, P.O. Box 231, 5600 AE Eindhoven, The Netherlands
    • Department of Public Health, Erasmus MC-University Medical Centre Rotterdam, Rotterdam The Netherlands
  • ,
  • the EUROCARE Working Group

Received 23 June 2008 ,Revised 24 October 2008 ,Accepted 10 November 2008.

References 

  1. Verdecchia A, De Angelis R, Capocaccia R, et al. The cure of colon cancer: results from the Eurocare study. Int J Cancer. 1998;77:322–329
  2. Berrino F, Sant M, Verdecchia A, et al. Survival of cancer patients in Europe. The EUROCARE Study. IARC scientific publications no. 132. Lyon: IARC; 1995;
  3. Berrino F, Capocaccia R, Estève J, et al. Survival of cancer patients in Europe. The EUROCARE-2 study. IARC scientific publications no. 151. Lyon: IARC; 1999;p. 1–572
  4. Berrino F, Capocaccia R, Coleman MP, et al. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol. 2003;14(5):v1–v155
  5. De Angelis R, Capocaccia R, Hakulinen T, Soderman B, Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med. 1999;18:441–454
  6. Farewell VT. The use of mixture models for the analysis of survival data with long term survivors. Biometrics. 1982;38:1041–1046
  7. Gamel JW, Vogel RL, Valagussa P, Bonadonna G. Parametric survival analysis of therapy for stage II breast cancer. Cancer. 1994;74:2483–2490
  8. De Angelis R, Francisci S, Baili P, et al. the EUROCARE Working Group The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis. Eur J Cancer. 2009;45:909–930
  9. SEER∗Stat release 6.3.6. <http://seer.cancer.gov/seerstat/>; 2003 [accessed 25.11.2007].
  10. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. J Natl Cancer Inst Monogr. 1961;6:101–121
  11. Henson DE, Ries LA. The relative survival rate. Cancer. 1995;76:1687–1688
  12. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982;39:933–942
  13. Brenner H, Francisci S, De Angelis R, et al. the EUROCARE Working Group Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer. 2009;45:1028–1041
  14. Berrino F, De Angelis R, Sant M, et al. Survival of eight major cancers and all cancers combined for European adults diagnosed in 1995–1999: results of the EUROCARE-4 study. Lancet Oncol. 2007;8:773–783
  15. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000–2002 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8:784–796
  16. Paci E, Miccinesi G, Puliti D, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res. 2006;8:R68
  17. Moss S. Overdiagnosis and over-treatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res. 2005;7:230–234
  18. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981–990
  19. Carpelan-Holmström M, Nordling S, Pukkala E, et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish cancer registry. Gut. 2005;54:385–387
  20. Coleman MP, Gatta G, Verdecchia A, et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003;14:128–149
  21. Obereigner W. Errors in survival rates caused by routinely used deterministic record linkage methods. Methods Inf Med. 2007;46:420–424
  22. Navarro C. The national death index: a largely expected advance in the access to mortality data. Gac Sanit. 2006;20(6):421–423
  23. Sant M, Francisci S, Capocaccia R, et al. Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer. 2006;119:2417–2422
  24. Tyczynski JE, Plesko I, Aareleid T, et al. Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer. 2004;112:1056–1062
  25. Coleman MP. Trends in breast cancer incidence, survival and mortality. Lancet. 2000;356:590–592
  26. Sant M, Allemani C, Santaquilani M, et al. the EUROCARE Working Group EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009;95:931–991
  27. Maggard MA, O’Connel JB, Lane KE, et al. Do young breast cancer patients have worse outcomes?. J Surg Res. 2003;113(1):109–113
  28. Thompson IM, Ankerst DP. Prostate-specific antigen in the early detection of prostate cancer. CMAJ. 2007;176(13):1853–1858
  29. D’Ambrosio G, Samani F, Cancian M, De Mola C. Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database. Eur J Cancer Prev. 2004;13:383–386
  30. Gavin A, McMarrin P, Middleton RJ, et al. Evidence of prostate cancer screening in a UK region. BJU Int. 2004;93:730–734
  31. Bouchardy C, Fioretta G, Rapiti E, et al. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer. 2008;123(2):421–429
  32. Pelzer AE, Bektic J, Akkad T, et al. Under-diagnosis and over-diagnosis of prostate cancer in a screening population with serum PSA 2 to 10ng/ml. J Urol. 2007;178(1):93–97
  33. Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA. 2007;298(5):518
  34. Sant M, Allemani C, Capocaccia R, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003;106:416–422
  35. Vainio H, Bianchini F, Heseltine E. IARC handbooks of cancer prevention: breast cancer screening. vol. 7. Lyon: IARC Press; 2002;p. 1–229

PII: S0959-8049(08)00918-0

doi: 10.1016/j.ejca.2008.11.034

European Journal of Cancer
Volume 45, Issue 6 , Pages 1067-1079 , April 2009